Provided by Tiger Trade Technology Pte. Ltd.

Qiagen NV

45.38
+0.85001.91%
Post-market: 45.380.00000.00%16:10 EDT
Volume:1.26M
Turnover:56.90M
Market Cap:9.35B
PE:23.07
High:45.61
Open:44.99
Low:44.79
Close:44.53
52wk High:57.82
52wk Low:32.53
Shares:206.00M
Float Shares:205.74M
Volume Ratio:0.43
T/O Rate:0.61%
Dividend:0.36
Dividend Rate:0.80%
EPS(TTM):1.97
EPS(LYR):2.04
ROE:11.93%
ROA:5.87%
PB:2.78
PE(LYR):22.22

Loading ...

Qiagen Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 06

Qiagen Q2 FY26 Adjusted Diluted EPS Rises to $0.62; Net Sales Hold at $535 Million

Reuters
·
Aug 06

Qiagen NV Q2 Adjusted EPS USD 0.62

Reuters
·
Aug 06

Qiagen Q2 Adj. EPS $0.62 Beats $0.60 Estimate, Sales $535.000M Beat $527.484M Estimate

Benzinga Earnings
·
Aug 06

Norges Bank Holds 3.1% Voting Rights in Qiagen, AFM Filing Shows

Reuters
·
Aug 05

Qiagen NV Expected to Post Earnings of 60 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Qiagen (QGEN) Stock Could Be A Cash Flow Bargain Yet Fair On Earnings

Simply Wall St.
·
Aug 01

Goldman Sachs Lifts Qiagen Voting Rights to 3.29% Via Higher Potential Stake

Reuters
·
Aug 01

BlackRock Lifts Qiagen Voting Rights to 13.04%, AFM Filing Shows

Reuters
·
Jul 30

Earning Preview: Qiagen NV this quarter’s revenue is expected to increase by 0.72%, and institutional views are overweight

Earnings Agent
·
Jul 29

Is Qiagen (QGEN) A Bargain On Its Infectious Disease Testing Push?

Simply Wall St.
·
Jul 28

UBS Holds 2.98% Voting Rights in Qiagen, AFM Filing Shows

Reuters
·
Jul 25

Barclays Lifts Qiagen Voting Rights Stake to 3.19%

Reuters
·
Jul 23

Blackrock Lifts Qiagen Voting Rights Stake to 13.53%

Reuters
·
Jul 18

Qiagen Flags Press Release on Molecular Testing Solutions for Rising US Cyclospora Outbreak

Reuters
·
Jul 16

Press Release: Qiagen N.V. to Release Results for Q2 2026 and Hold Webcast

Dow Jones
·
Jul 15

Qiagen Updates Financial Calendar with Q2 2026 Results Release and Webcast Schedule

Reuters
·
Jul 15

Qiagen Launches QIAstat-Dx Bloodstream Infection Testing in Europe

MT Newswires Live
·
Jul 15

Berenberg Downgrades QIAGEN to Hold From Buy, Cuts Price Target to $45.50 From $59

MT Newswires Live
·
Jul 14

Qiagen downgraded to Hold from Buy at Berenberg

TIPRANKS
·
Jul 14